Continuing

Education

Continuing

Education

CATEGORY

What’s New in Mitral Valve Disease: The 2019 ACVIM Guidelines and Spironolactone Story (Cardiology)

RACE-Approved 1 Hour CE Course

This presentation is a practical, clinically relevant review of the latest updates in the diagnosis and management of mitral valve disease in dogs. Recent data, including the 2021 BESST study and 2019 ACVIM guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs, will be discussed with tips to apply the findings to your daily practice.

BESST Study: BEnazepril Spironolactone STudy (for the General Practitioner) (Cardiology)

RACE-Approved 1 Hour CE Course

This course explores new concepts in the management of congestive heart failure. Dr. Atkins will introduce a new product—CARDALIS™, alongside the results of the BESST Study. Through his presentation of the BESST study data, this course will provide a concept of more complete RAAS Suppression and walk through how that fits into YOUR practice.

BESST Study: Benazepril Spironolactone STudy (Cardiology)

RACE-Approved 1 Hour CE Course

The pivotal trial for Cardalis will be described in detail, with methods and results. Clinical applications for this drug will also be discussed. The attendee will learn how the drug was evaluated and of its efficacy and safety.

DELAY Study: DELay of Appearance of sYmptoms of canine degenerative mitral valve disease treated with spironolactone and benazepril (Cardiology)

RACE-Approved 0.5 Hour CE Course

Dr. Borgarelli will provide a review of the DELAY study. He will touch on the prognostic significance of cardiac remodeling in dogs with MMVD and how cardiac biomarkers can be used in clinical trials.

Rational Dose Selection for ACE Inhibitors in Canine Heart Disease (Cardiology)

RACE-Approved 0.5 Hour CE Course

Although ACE inhibitors are among the most commonly prescribed medications in veterinary cardiology, no consensus exists on the ideal dose of ACEi for treatment of heart disease, systemic hypertension, or proteinuria. The purpose of this presentation is to review the existing evidence and future research directions that can assist clinicians in choosing the optimal dose of ACEi for their patients.

Staff Rewards

START SAVING

Connect with Ceva

VIEW NEWS

Customer Service

CONTACT US

Ceva Animal Health offers many products designed to help keep pets healthier inside and out. Learn more about our company by visiting www.ceva.us.

© 2017 Ceva Animal Health, LLC
Terms of Use | Cookies Policy | Privacy Policy